Cross Country Healthcare, Inc. (CCRN) स्टॉक विश्लेषण

कंपनी का अवलोकन

Cross Country Healthcare, Inc. operates within the United States market by providing comprehensive talent management services specifically tailored for healthcare clients. The organization functions as a staffing agency that manages the recruitment and deployment of medical personnel across two primary segments: Nurse and Allied Staffing, and Physician Staffing. Within the Nurse and Allied Staffing segment, the company delivers traditional staffing solutions, recruiting services, and value-added support to its clients. This enterprise is classified under the Healthcare sector and specifically within the Medical Care Facilities industry, a classification that defines its core business model as connecting healthcare providers with necessary staffing resources. The company currently holds a market capitalization of $305.41M and generates annual revenue of $1.05B, supported by a workforce of 7,890 employees. These financial metrics indicate that while the company possesses a substantial operational footprint, its valuation reflects a smaller-cap status relative to large-scale hospital operators or integrated health systems. The revenue figure of $1.05B suggests a significant volume of transactions in the temporary staffing market, yet the market cap of $305.41M implies that the market values the company based on future earnings potential rather than current profitability, given the negative net income reported in the trailing twelve months.

वित्तीय स्वास्थ्य

The company reported a total revenue of $1.05B over the trailing twelve months, yet it recorded a net income of -$94,852,000 and an EBITDA of $18.53M for the same period. The substantial gap between the $1.05B revenue and the negative net income of -$94,852,000 reveals a highly leveraged cost structure where operating expenses, likely driven by payroll and recruitment costs, significantly erode bottom-line profitability despite high top-line activity. Despite the negative net income, the company generated positive free cash flow of $42.77M, which indicates a degree of financial flexibility allowing the firm to fund operations and potentially return capital without immediate reliance on external equity financing. The company maintains a cash balance of $108.74M against a total debt load of only $2.32M, resulting in a debt-to-equity ratio of 0.72, which suggests a conservative balance sheet with minimal leverage risk relative to its equity base. Liquidity is further strengthened by a current ratio of 3.78, indicating that the company holds 3.78 times more current assets than current liabilities, providing a robust buffer against short-term obligations. Profitability metrics are under pressure, evidenced by a gross margin of 20.3%, an operating margin of -0.6%, and a profit margin of -9.0%, which collectively signal that the company is currently operating at a loss on a per-share basis. Return on equity stands at -25.6% while return on assets is 0.3%, metrics that reveal management is currently unable to generate positive returns on shareholder capital or the asset base utilized to generate revenue.

मूल्यांकन आकलन

Valuation multiples for the company show a trailing P/E ratio of N/A due to the negative net income, while the forward P/E is 33.75, implying that the market is pricing in a significant turnaround in earnings expected to occur in the near future. The price-to-book ratio is 0.93, indicating that the market values the company at 93% of its book value, which suggests the stock is trading at a discount to the net asset value of the firm. Alternative valuation metrics provide further context, with a price-to-sales ratio of 0.29 and an EV/EBITDA of 10.74, suggesting the market is valuing the firm primarily on its sales volume and adjusted earnings power rather than current profitability. The stock's price volatility is moderate, with a beta of 0.34, indicating that the stock price moves at roughly one-third the magnitude of the broader market index. Over the past year, the stock price has ranged between a 52-week high of $15.01 and a 52-week low of $7.43, currently trading within this historical band. The wide spread between the high and low suggests high price sensitivity to market sentiment regarding the healthcare staffing sector, while the low beta confirms that the stock is less volatile than the overall market.

Growth & Income

Revenue growth for the company declined by 23.6% year-over-year, while earnings growth is N/A due to the negative net income position. The contraction in revenue indicates a challenging operating environment or a loss of market share in the competitive staffing landscape, and the absence of earnings growth reinforces that the business is currently in a restructuring or loss-making phase. The company does not pay a dividend, as indicated by a dividend yield of N/A and a payout ratio of 0.0%, meaning the firm retains all of its earnings rather than distributing them to shareholders. This reinvestment strategy is typical for companies in turnaround situations or those with negative earnings, as they prioritize capital allocation toward operational improvements over shareholder payouts. The overall growth and income profile reflects a company in a transitionary period with negative earnings growth and zero dividend income, relying instead on cash flow generation and balance sheet strength to navigate the current revenue decline.